References
- Clemens ET, Maloyi GMO. (1981). Organic acid concentrations and digesta movement in the gastrointestinal tract of the bushbaby (Galago crassicaudatus) and Vervet monkey (Cercopithecidae pygerythrus). J Zool (Lond) 193:487–497.
- El Dareer SM, Struck RF, White VM, Mellett LB, Hill DL. (1977). Distribution and metabolism of prednisone in mice, dogs, and monkeys. Cancer Treat Rep 61:1279–1289.
- Evans CA, Jolivette LJ, Nagilla R, Ward KW. (2006). Extrapolation of preclinical pharmacokinetics and molecular feature analysis of ‘discovery-like’ molecules to predict human pharmacokinetics. Drug Metab Disposit 34:1255–1265.
- Friedman H, Redmond DEJr, Greenblatt DJ. (1991). Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys. Psychopharmacology 104:103–105.
- Kola I, Landis J. (2004). Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Disc 3:711–715.
- Lee AM, Yue J, Tyndale RF. (2006). In vivo and in vitro characterization of chlorzoxazone metabolism and hepatic CYP2E1 levels in African green monkeys: induction by chronic nicotine treatment. Drug Metab Disposit 34:1508–1515.
- Ludden TM. (1991). Nonlinear pharmacokinetics: clinical implications. Clin Pharmacokinet 20:429–446.
- Rabot S, Viso M, Martin F, Blanquie J-P, Popot F, Bensaada M, Vaissade P, Searby N, Szylit O. (1997). Effect of chair-restraint on gastrointestinal time and colonic fermentation in male rhesus monkey (Macaca mulatta). J Med Primatol 26:190–195.
- Tang H, Hussain A, Leal M, Mayersohn M, Fluhler E. (2007). Interspecies prediction of human drug clearance based on scaling data from one or two animal species. Drug Metab Disposit 35:1886–1893.
- Ward KW, Coon DJ, Magiera D, Bhadresa S, Nisbett E, Lawrence MS. (2008). Exploration of the African green monkey as a preclinical pharmacokinetic model: intravenous pharmacokinetic parameters. Drug Metab Disposit 36:715–720.
- Ward KW, Nagilla R, Jolivette LJ. (2005). Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey, and human. Xenobiotica 35:191–201.
- Ward KW, Proksch JW, Levy MA, Smith BR. (2001). Development of an in vivo preclinical screen model to estimate absorption and bioavailability of xenobiotics. Drug Metab Disposit 29:82–88.
- Ward KW, Smith BR. (2004). A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance. Drug Metab Disposit 32:603–611.
- Ward KW, Stelman GJ, Morgan JA, Zeigler KS, Azzarano LM, Kehler JR, McSurdy-Freed JE, Proksch JW, Smith BR. (2004). Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey. Drug Metab Disposit 32:172–177.